This result reflects the different and age-dependent risk of cancer development associated with the two genes: the breast cancer peak of incidence occurs earlier and ovarian cancer risk is higher in BRCA1 carriers as compared to those with BRCA2 pathogenic variants19,20. The gene discussed is BRCA1; the disease is breast cancer.